Redefining Healthcare Through Biomaterials and Nanotechnology
Keywords:
biomaterials, nanotechnology, healthcareAbstract
In recent years, biomaterials and nanotechnology have emerged as twin pillars of innovation, redefining the landscape of biomedical research and clinical translation. What was once considered futuristic - smart scaffolds for regeneration, nanosensors for real-time diagnostics, bioactive composites for infection control - has now become an accelerating reality in laboratories and clinics worldwide. The convergence of advanced materials science with nanotechnology has created a paradigm shift: not merely improving existing therapies, but fundamentally reimagining how we approach health, disease, and regeneration. From sustainable and recycled biomaterials for dentistry and orthopedics, to quantum dots, nanoparticles, and carbon nanotubes enabling unprecedented precision in diagnostics and therapy, the scope of applications is expanding at a remarkable pace. Equally transformative are the innovations in antimicrobial coatings and nanostructured composites, offering much-needed solutions against biofilm formation and hospital-acquired infections. Nano-enabled diagnostics and therapeutic platforms, such as biosensors, lab-on-a-chip systems, and targeted drug delivery vehicles, are bridging the gap between molecular insight and bedside care. Parallelly, the resurgence of bioactive natural compounds in nanocarrier systems underscores how tradition and technology can unite to address inflammation, wound healing, and tissue regeneration.
This special issue curates’ interdisciplinary contributions that highlight the momentum and maturity of this field. Beyond the science itself, the larger significance lies in what these innovations promise: eco-friendly, biocompatible, and translational solutions that align with the global demand for sustainable healthcare. Dentistry, orthopedics, regenerative medicine, and personalized healthcare stand to benefit immensely as these advances move from bench to bedside.
This collection has proven to be more than a snapshot of current progress—it stands as a testament to bold thinking, wide collaboration, and the relentless pursuit of pushing the boundaries of what biomaterials and nanotechnology can achieve. By weaving together fundamental discoveries with clinical utility, it has illuminated a new era in which biomedical engineering not only treats disease but actively restores, regenerates, and redefines health.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ramya Ramadoss (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Licensing
All articles published in Trends in Biomaterials and Artificial Organs are published Open Access. To ensure the widest possible dissemination of research while protecting the integrity of the original work, we utilize the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 4.0 International License.
User Rights
Under this license, the public is free to share (copy and redistribute the material in any medium or format) under the following terms:
- Attribution: Users must give appropriate credit, provide a link to the license, and indicate if changes were made.
- Non-Commercial: Users may not use the material for commercial purposes. This includes, but is not limited to, the sale of the article or its use in promotional materials for-profit.
- No Derivatives: If a user remixes, transforms, or builds upon the material, they may not distribute the modified material.
Author Rights
Authors retain copyright of their work while granting the journal a non-exclusive license to publish. Because of the NoDerivs (ND) and Non-Commercial (NC) designations:
- Third parties (such as other researchers) must seek permission from the authors/journal to include figures, tables, or portions of the text in new works or commercial publications.
- Authors may deposit the "Version of Record" in institutional repositories immediately upon publication, provided the CC BY-NC-ND 4.0 license is clearly linked.


